Journal Report

Acta Neurologica Belgica

Download PDF
Journal Information
Journal Title
Acta Neurologica Belgica
Publisher
Springer Science and Business Media Deutschland GmbH
ISSN
0300-9009
E-ISSN
2240-2993
Database
SCOPUS
Domain
Health Sciences, Life Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Assessment of fine motor performance and motor speed in pediatric patients with juvenile myoclonic epilepsy
Sevinc Mertoglu, Peren Perk, Pinar Arican
2026-10-26
Laparoscopic versus open approaches for ventriculoperitoneal shunt placement in children: a systematic review and meta-analysis
Shitong Hu, Yehang Zhu, Qingqing Deng et al.
2026-10-26
Cognitive-communication features relevant to speech and language therapy in Lewy Body Dementia
Georgia Konstantopoulou, Efterpi Elpida Kyriazi, Panagiotis Felemegkas et al.
2026-10-26
Left vertebral artery arising from the aortic arch with right vertebral artery arising from the common carotid artery
Yumeng Hu, Yuxi Wu
2026-10-22
De novo appearance of early venous filling in the subacute phase after mechanical thrombectomy
Yuhei Ito, Megumi Koiwai, Takamitsu Saito et al.
2026-10-21
Progressive hemifacial atrophy, AQP4-positive NMOSD and suspected Sjögren’s syndrome: five-year relapse-free follow-up during rituximab therapy
Yan Liu, Siyuan Song, Xiaochao Feng et al.
2026-10-21
Cutaneous allodynia across MIDAS disability grades in episodic migraine: a cross-sectional analysis
Mehmet Mühürdaroğlu
2026-10-17
Clinical characteristics of headache in the patients with Neuro-Behçet’s disease
Ayşegül Şeyma Sarıtaş, Yağmur İnalkaç Gemici, Melike Batum et al.
2026-10-15
Clinical and radiological characteristics of MOG antibody-associated disease (MOGAD): a comparative study between pediatric and adult cohorts
Ahmet Kasim Kilic, Hanife Senturk, Safiye Gunes Sager
2026-10-14
Comparative effectiveness and safety of rituximab versus ocrelizumab in relapsing–remitting multiple sclerosis: a real-world experience from Iran
Fatemeh Meshkini, Nahid Beladi Moghaddam, Mehran Ghaffari et al.
2026-10-14
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: October 30, 2026 13:10